Cargando…
CEO Regulatory Focus, Analysts’ Optimism Bias, and Firm Strategic Change: Evidence From Chinese-Listed Companies
With the ongoing coronavirus disease 2019 (COVID-19) pandemic, technological, socio-political, and institutional changes have led to a “new normal” competitive landscape, firms must make longer-term strategic changes to deal with short-term discontinuities and great uncertainties to acquire sustaina...
Autores principales: | Huang, Chun, Zheng, Wangxiongjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988178/ https://www.ncbi.nlm.nih.gov/pubmed/35401381 http://dx.doi.org/10.3389/fpsyg.2022.813920 |
Ejemplares similares
-
Celebrity CEOs and firm innovation investment: Evidence from Chinese-listed companies
por: Shao, Dong, et al.
Publicado: (2022) -
CEO turnover and corporate innovation: What can we learn from Chinese listed companies
por: Sun, Shujun, et al.
Publicado: (2022) -
Data of CEO power, chair-CEO age dissimilarity and pay gap of Chinese listed firms
por: ZHU, Jiajun, et al.
Publicado: (2020) -
Economic Policy Uncertainty and Family Firm Innovation: Evidence From Listed Companies in China
por: Qi, Yong, et al.
Publicado: (2022) -
Demonstrating the Impact of Cognitive CEO on Firms’ Performance and CSR Activity
por: Li, Hui, et al.
Publicado: (2020)